Remain invested in Strides Shasun: Shahina Mukadam

Shahina Mukadam, Independent Market Expert told CNBC-TV18, "I would continue to hold Strides Shasun for some time now. I believe that very recently the company has got some approval from USFDA for launch of two products and these are the first approvals it has got from its Bangalore facility. After all the restructuring the company had done they were in this phase where they were getting their plants in place. I think one should wait and the investor should get a better exit. I would give it closer to Rs 800, so I would advise to wait."

At 15:14 hrs Strides Shasun was quoting at Rs 701.60, down Rs 22.15, or 3.06 percent.